Geron (GERN) Gains from Equity Investments (2018 - 2020)
Geron (GERN) posted Gains from Equity Investments of $24000.0 for Q4 2020, down 73.91% sequentially from $92000.0 in Q3 2020, and up 250.0% YoY from $6857.1 in Q1 2020.
Geron (GERN) Gains from Equity Investments (2018 - 2020) Analysis & Trends
Geron has reported Gains from Equity Investments for 3 years, with the latest figure at $24000.0 in Q4 2020.
- Quarterly Gains from Equity Investments rose 250.0% year-over-year to $24000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was -$163000.0 (down 183.16% YoY) and the FY2020 annual result came in at -$163000.0, down 183.16% from the prior year.
- Gains from Equity Investments eased to $24000.0 in Q4 2020 per GERN's latest filing, from $92000.0 in the prior quarter.
- Over five years, Gains from Equity Investments peaked at $388000.0 in Q2 2018 and troughed at -$499000.0 in Q2 2020.
- A 3-year average of $53083.3 and a median of $99000.0 in 2019 frame the typical range for Gains from Equity Investments.
- The widest YoY moves for Gains from Equity Investments: up 313.59% in 2020, down 570.75% in 2020.
- Over 3 years, Gains from Equity Investments stood at $266000.0 in 2018, then slumped by 106.02% to -$16000.0 in 2019, then jumped by 250.0% to $24000.0 in 2020.
- According to Business Quant data, Gains from Equity Investments over the past three periods registered $24000.0, $92000.0, and -$499000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 24,000.00 |
| Dec 31, 2020 | 24,000.00 |
| Sep 30, 2020 | 92,000.00 |
| Sep 30, 2020 | 92,000.00 |
| Jun 30, 2020 | -499,000.00 |
| Jun 30, 2020 | -499,000.00 |
| Mar 31, 2020 | 220,000.00 |
| Mar 31, 2020 | 220,000.00 |
| Dec 31, 2019 | -16,000.00 |
| Dec 31, 2019 | -16,000.00 |
| Sep 30, 2019 | 209,000.00 |
| Sep 30, 2019 | 209,000.00 |
| Jun 30, 2019 | 106,000.00 |
| Jun 30, 2019 | 106,000.00 |
| Mar 31, 2019 | -103,000.00 |
| Mar 31, 2019 | -103,000.00 |
| Dec 31, 2018 | 266,000.00 |
| Dec 31, 2018 | 266,000.00 |
| Sep 30, 2018 | -175,000.00 |
| Sep 30, 2018 | -175,000.00 |